Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (ALNY) Q1 2023 Earnings
ALNY
23
Feb
Confirmed
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-2.69
-2.34
-1.98
-1.63
Details
Expected EPS
-1.95
Actual EPS
-1.68
Surprise EPS
0.27
Surprise Percent
+13.85%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.68 per share for Q1 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login